作者投稿
专家审稿
编辑办公
邮件订阅
RSS
Clinical and Pathological Characteristics and Treatment Outcome of Sarcoma of the Larynx
-
摘要:
目的 探讨喉部肉瘤的临床病理特征及其预后影响因素。 方法 回顾性分析北京协和医院耳鼻咽喉科1990年1月至2008年12月期间住院治疗的13例喉部肉瘤患者的临床资料, 分析肿瘤的临床病理特性, 以Kaplan-Meier法进行生存率统计并分析临床分期和组织学分级与生存率的关系。 结果 喉部肉瘤患者以男性为主(9/13), 含7种病理类型:恶性纤维组织细胞瘤、平滑肌肉瘤、横纹肌肉瘤、滑膜肉瘤、软骨肉瘤、神经纤维肉瘤、癌肉瘤。12例接受手术治疗, 其中7例术后进行了放疗和/或化疗; 另1例仅行放疗。全部病例平均随访29.3个月, 其中5例出现局部复发, 1例出现远处转移, 5年生存率为38.0%。临床分期和组织学分级对生存率有明显影响(P < 0.05)。 结论 喉部肉瘤预后差, 临床分期和组织学分级与预后相关。 Abstract:Objective To determine the clinical and pathological characteristics as well as outcome of sarcoma of the larynx. Methods A retrospective review of 13 patients with laryngeal sarcoma treated in Peking Union Medical College Hospital from January 1990 to December 2008 was taken to identify clinical characteristics, pathological characteristics, and therapeutic modalities. Kaplan-Meier survivals were compared according to T-stage and histological G-grade. Results Sarcoma of the larynx showed a male predominance in all cases (9/13) and presented 7 pathological types:maglignant fibrous histiocytoma, leiomyosarcoma, rhabdomyosarcoma, synovial sarcoma, chondrosarcoma, neurofibrosarcoma, carcinosarcoma. Twelve cases underwent tumor resection, including partial laryngectomy, total laryngectomy, and endoscopic resection. Among them, 7 cases underwent postoperative radiological therapy and/or chemical therapy. Another case only received radiological therapy. The average follow up time of all cases was 29.3 months and five-year survival rate was 38.0%. Local recurrence occurred in 5 cases and distant metastasis in 1 case. Survival rate was significantly different according to T-stage and histological G-grade (log-rank, P < 0.05). Conclusions Sarcomas of the larynx show poor prognosis. The factors influencing survival rate include T-stage and G-grade. -
Key words:
- laryngeal neoplasms /
- sarcoma /
- prognosis /
- laryngectomy
-
表 1 13例喉部肉瘤患者的临床病理资料
病例 性别 年龄(岁) 原发部位 分期 分级 病理类型 治疗方案 手术方案 结局 1 男 32 声门上 T1N0M0 G3 横纹肌肉瘤 手术+放疗+化疗 喉全切除术 14个月复发死亡 2 男 43 声门上 T2N0M0 G3 神经纤维肉瘤 放疗 无 6个月放弃治疗失访 3 男 57 声门 T1N1M0 G1 平滑肌肉瘤 手术 喉全切除术 无瘤生存(随访至25个月) 4 男 54 声门上 T1N1M0 G2 平滑肌肉瘤 手术+放疗 喉全切除术 22个月复发死亡 5 男 54 声门 T1N0M0 G1 癌肉瘤 手术 喉全切除术 无瘤生存(随访至62个月) 6 男 68 声门 T1N0M0 G2 癌肉瘤 手术+放疗 喉部分切除术 12个月后失访 7 男 35 声门 T1N0M0 G1 软骨肉瘤 手术 喉部分切除术 无瘤生存(随访至66个月) 8 女 70 声门上 T2N0M0 G2 滑膜肉瘤 手术 喉全切除术 38个月复发死亡 9 男 39 声门上 T2N0M0 G2 滑膜肉瘤 手术+放疗+化疗 喉部分切除术 20个月复发死亡 10 男 52 声门 T1N0M0 G1 癌肉瘤 手术+放疗 喉镜下切除手术 无瘤生存(随访至70个月) 11 女 46 声门 T1N1M0 G3 横纹肌肉瘤 手术+放疗+化疗 喉部分切除术 16个月远处转移死亡 12 女 38 声门上 T1N0M0 G1 恶性纤维组织细胞瘤 手术 喉部分切除术 无瘤生存(随访至24个月) 13 女 73 声门上 T2N0M0 G2 恶性纤维组织细胞瘤 手术+放疗 喉部分切除术 6个月复发死亡 
下载: 导出CSV
-
[1] Lin HW, Bhattacharyya N. Staging and survival analysis for nonsquamous cell carcinomas of the larynx[J]. Laryngoscope, 2008, 118:1003-1013. doi: 10.1097/MLG.0b013e3181671b3d [2] Eeles RA, Fisher C, A'Hern RP, et al. Head and neck sarcomas:prognostic factors and implications for treatment[J]. Br J Cancer, 1993, 68:201-207. doi: 10.1038/bjc.1993.314 [3] American Joint Committee on Cancer. Soft tissue sarcoma[M]//Cancer staging manual. 7th ed. New York: Springer, 2010: 291-298. [4] Farhood AI, Hajdu SI, Shiu MH, et al. Soft tissue sarcomas of the head and neck in adults[J]. Am J Surg, 1990, 160:365-369. doi: 10.1016/S0002-9610(05)80544-6 [5] Havens FZ, Parkhill EM. Tumors of the larynx other than squamous cell epithelioma[J]. Arch Otolaryngol, 1941, 34:1113-1122. doi: 10.1001/archotol.1941.00660041207004 [6] Levine HL, Tubbs R. Nonsquamous neoplasms of the larynx[J]. Otolaryngol Clin North Am, 1986, 19:475-488. doi: 10.1016/S0030-6665(20)31740-0 [7] Kraus DH, Dubner S, Harrison LB, et al. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas[J]. Cancer, 1994, 74:697-702. doi: 10.1002/1097-0142(19940715)74:2<697::AID-CNCR2820740224>3.0.CO;2-A [8] Rodel RMW, Steiner W, Muller RM, et al. Endoscopic laser surgery of early glottic cancer:involvement of the anterior commissure[J]. Head Neck, 2009, 31:219-222. http://new.med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_JJ028304487 [9] 黄志刚, 韩德民. CO2激光手术治疗声门型喉癌疗效分析[J].中华耳鼻咽喉杂志, 2002, 37:219-222. http://d.wanfangdata.com.cn/Periodical/zhebyhk200203017 [10] Le QT, Fu KK, Kroll S, et al. Prognostic factors in adult soft tissue sarcomas of the head and neck[J]. Int J Radiat Oncol Biol Phys, 1997, 37:975-984. doi: 10.1016/S0360-3016(97)00103-X [11] Pellitteri PK, Ferlito A, Bradley PJ, et al. Management of sarcomas of the head and neck in adults[J]. Oral Oncol, 2003, 39:2-12. doi: 10.1016/S1368-8375(02)00032-5 [12] Edmonson J. Chemotherapeutic approaches to soft tissue sarcomas[J]. Sem Surg Oncol, 1994, 10:357-363. doi: 10.1002/ssu.2980100508 [13] Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-Ⅰ. A final report[J]. Cancer, 1988, 61:209-220. doi: 10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L [14] Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-Ⅱ[J]. Cancer, 1993, 71:1904-1922. doi: 10.1002/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X [15] Crist W, Gehan EA, Ragab AH, et al. The Third Intergoup Rhabdomyosarcoma Study[J]. J Clin Oncol, 1995, 13:610-630. doi: 10.1200/JCO.1995.13.3.610 [16] Crist WM, Anderson JR, meza JL, et al. Intergroup rhabdomyosarcoma study-Ⅳ:results for patients with nonmetastatic disease[J]. J Clin oncol, 2001, 19:3091-3102. doi: 10.1200/JCO.2001.19.12.3091 [17] Combs SE, Behnisch W, Kulozik AE, et al. Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head and neck rhabdomyosarcoma[J]. BMC Cancer, 2007, 7:177. doi: 10.1186/1471-2407-7-177 [18] Kusuma S, Skarupa DJ, Ely KA, et al. Synovial sarcoma of the head and neck:a review of its diagnosis and management and a report of a rare case of orbital involvement[J]. Ear Nose Throat J, 2010, 89:280-283. doi: 10.1177/014556131008900612 [19] Odell PF. Head and neck sarcomas:a review[J]. J Otolaryngol, 1996, 25:7-12. http://www.ncbi.nlm.nih.gov/pubmed/8816102 [20] Pittore B, Fancello G, Cossu Rocca P, et al. Rhabdomyosarcoma:a rare laryngeal neoplastic entity[J]. Acta Otorhinolaryngol Ital, 2010, 30:52-57. http://europepmc.org/articles/PMC2881606/ [21] Rizzo S, Strinati F. Chondrosarcoma of the larynx:presentation of a case and review of the literature[J]. Tumori, 2008, 94:864-868. doi: 10.1177/030089160809400617 [22] Kanotra SP, Kanotra S. Chondrosarcoma of the arytenoid cartilage[J]. Ear Nose Throat J, 2010, 89:E6-E10. http://www.ncbi.nlm.nih.gov/pubmed/20155689 -
点击查看大图
图(3) / 表(1)
计量
- 文章访问数: 215
- HTML全文浏览量: 63
- PDF下载量: 5
- 被引次数: 0
